Substrate specificity of human metallocarboxypeptidase D: Comparison of the two active carboxypeptidase domains.
| Citation | Garcia-Pardo, Javier, et al. “Substrate Specificity of Human Metallocarboxypeptidase D: Comparison of the Two Active Carboxypeptidase Domains”. 2017. PloS One, vol. 12, no. 11, 2017, p. e0187778.  | 
       
| Center | Albert Einstein College of Medicine | 
| Author | Javier Garcia-Pardo, Sebastian Tanco, Lucía Díaz, Sayani Dasgupta, Juan Fernandez-Recio, Julia Lorenzo, Francesc X Aviles, Lloyd D Fricker | 
| Abstract | 
   Metallocarboxypeptidase D (CPD) is a membrane-bound component of the trans-Golgi network that cycles to the cell surface through exocytic and endocytic pathways. Unlike other members of the metallocarboxypeptidase family, CPD is a multicatalytic enzyme with three carboxypeptidase-like domains, although only the first two domains are predicted to be enzymatically active. To investigate the enzymatic properties of each domain in human CPD, a critical active site Glu in domain I and/or II was mutated to Gln and the protein expressed, purified, and assayed with a wide variety of peptide substrates. CPD with all three domains intact displays >50% activity from pH 5.0 to 7.5 with a maximum at pH 6.5, as does CPD with mutation of domain I. In contrast, the domain II mutant displayed >50% activity from pH 6.5-7.5. CPD with mutations in both domains I and II was completely inactive towards all substrates and at all pH values. A quantitative peptidomics approach was used to compare the activities of CPD domains I and II towards a large number of peptides. CPD cleaved C-terminal Lys or Arg from a subset of the peptides. Most of the identified substrates of domain I contained C-terminal Arg, whereas comparable numbers of Lys- and Arg-containing peptides were substrates of domain II. We also report that some peptides with C-terminal basic residues were not cleaved by either domain I or II, showing the importance of the P1 position for CPD activity. Finally, the preference of domain I for C-terminal Arg was validated through molecular docking experiments. Together with the differences in pH optima, the different substrate specificities of CPD domains I and II allow the enzyme to perform distinct functions in the various locations within the cell.  | 
        
| Year of Publication | 
   2017 
           | 
        
| Journal | 
   PloS one 
           | 
        
| Volume | 
   12 
           | 
        
| Issue | 
   11 
           | 
        
| Number of Pages | 
   e0187778 
           | 
        
| Date Published | 
   12/2017 
           | 
        
| ISSN Number | 
   1932-6203 
           | 
        
| DOI | 
   10.1371/journal.pone.0187778 
           | 
        
| Alternate Journal | 
   PLoS ONE 
           | 
        
| PMCID | 
   PMC5683605 
           | 
        
| PMID | 
   29131831 
           | 
        
| Download citation |